REATA PHARMACEUTICALS INC reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Plano, TX
SEC filing record 1 source field available
Fiscal year end
31 December
REATA PHARMACEUTICALS INC has filed 702 SEC EDGAR filings since 27 Mar 2006

SEC filing history

Showing 426-450 of 697 matching filings.

Per page
25
Current page
18
8-K File 001-37785

8-K PHOENIX - IGA NEPHROPATHY DATA

Filing date
25 Sep 2018
Reporting date
25 Sep 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37785

8-K

Filing date
08 Aug 2018
Reporting date
08 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-89517

SC 13D/A filing

Filing date
31 Jul 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-89517

SCHEDULE 13D/A (AMENDMENT NO. 4)

Filing date
31 Jul 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-89517

SC 13D/A

Filing date
31 Jul 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
26 Jul 2018
Reporting date
25 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37785

8-K 2018.07_UNDERWRITING AG

Filing date
26 Jul 2018
Reporting date
24 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-226289

424B5

Filing date
26 Jul 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
25 Jul 2018
Reporting date
23 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-226289

424B5

Filing date
23 Jul 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3ASR File 333-226289

S-3ASR

Filing date
23 Jul 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37785

8-K JUNE 30, 2018 CASH BALANCE

Filing date
23 Jul 2018
Reporting date
23 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37785

8-K CARDINAL PHASE 2 48/52 WEEK DATA

Filing date
23 Jul 2018
Reporting date
23 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Jul 2018
Reporting date
05 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Jun 2018
Reporting date
13 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jun 2018
Reporting date
13 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37785

8-K REATA-OXFORD TERM LOAN

Filing date
14 Jun 2018
Reporting date
14 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2018
Reporting date
13 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2018
Reporting date
13 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2018
Reporting date
13 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37785

8-K ANNUAL MEETING RESULTS

Filing date
13 Jun 2018
Reporting date
13 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
07 Jun 2018
Reporting date
05 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37785

8-K PHOENIX ADPKD

Filing date
25 May 2018
Reporting date
25 May 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .